Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Rare cancer

Clinical Features of Li-Fraumeni Syndrome in Korea

Ran Song, Sun-Young Kong, Wonyoung Choi, Eun-Gyeong Lee, Jaeyeon Woo, Jai Hong Han, Seeyoun Lee, Han-Sung Kang, So-Youn Jung

Cancer Res Treat. 2024;56(1):334-341. Published online August 9, 2023 DOI: https://doi.org/10.4143/crt.2023.794

Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma

Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li

Cancer Res Treat. 2020;52(3):925-937. Published online March 30, 2020 DOI: https://doi.org/10.4143/crt.2019.533

Web of Science 9 Crossref 9

EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia

Dan-Min Xu, Yi-Lin Kong, Li Wang, Hua-Yuan Zhu, Jia-Zhu Wu, Yi Xia, Yue Li, Shu-Chao Qin, Lei Fan, Jian-Yong Li, Jin-Hua Liang, Wei Xu

Cancer Res Treat. 2020;52(2):492-504. Published online October 29, 2019 DOI: https://doi.org/10.4143/crt.2019.457

Web of Science 9 Crossref 7

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer

Ah-Rong Nam, Mei Hua Jin, Ji Eun Park, Ju-Hee Bang, Do-Youn Oh, Yung-Jue Bang

Cancer Res Treat. 2019;51(3):1167-1179. Published online December 3, 2018 DOI: https://doi.org/10.4143/crt.2018.526

Web of Science 20 Crossref 20

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer

Ji-Yeon Kim, Kyunghee Park, Hae Hyun Jung, Eunjin Lee, Eun Yoon Cho, Kwang Hee Lee, Soo Youn Bae, Se Kyung Lee, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park

Cancer Res Treat. 2016;48(4):1338-1350. Published online February 18, 2016 DOI: https://doi.org/10.4143/crt.2015.430

Web of Science 49 Crossref 44

The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer

Hae-Yun Jung, Hyun-Jung Joo, Jong Kuk Park, Yeul Hong Kim

Cancer Res Treat. 2012;44(4):251-261. Published online December 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.4.251

Crossref 15

Role of Loss of O⁶-Methylguanine DNA Methyltransferase (MGMT) Expression in Non-Small Cell Lung Carcinomas (NSCLCs): with Reference to the Relationship with p53 Overexpression

Na-Hye Myong

Cancer Res Treat. 2010;42(2):95-100. Published online June 30, 2010 DOI: https://doi.org/10.4143/crt.2010.42.2.95

Crossref 5

p53 Prevents Immature Escaping from Cell Cycle G2 Checkpoint Arrest through Inhibiting cdk2-dependent NF-Y Phosphorylation

Un-Jung Yun, Heui-Dong Park, Deug Y Shin

Cancer Res Treat. 2006;38(4):224-228. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.224

Crossref 7

Prognostic Significance of Immunohistochemical Expression of p53 Gene Product in Operable Breast Cancer

Hong Suk Song, Young Rok Do, Sun Hee Kang, Ki Yong Jeong, Yu Sa Kim

Cancer Res Treat. 2006;38(4):218-223. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.218

Crossref 11

Cell Cycle Regulatory Protein Expression Profiles by Adenovirus p53 Infection in Human Papilloma Virus-associated Cervical Cancer Cells

Yong-Seok Lee, Su-Mi Bae, Sun-Young Kwak, Dong-Chun Park, Yong-Wook Kim, Soo-Young Hur, Eun-Kyung Park, Byoung-Don Han, Young-Joo Lee, Chong-Kook Kim, Do Kang Kim, Woong-Shick Ahn

Cancer Res Treat. 2006;38(3):168-177. Published online June 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.3.168

Crossref 6

Thymidylate Synthase, Thymidine Phosphorylase, VEGF and p53 Protein Expression in Primary Colorectal Cancer for Predicting Response to 5-fluorouracil-based Chemotherapy

Myung-Ju Ahn, Jung-Hye Choi, Ho-Suk Oh, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Kang-Hong Lee, Kang-Won Song, Chan-Kum Park

Cancer Res Treat. 2005;37(4):216-222. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.216

Crossref 5

Expression of c-kit and p53 in Non-small Cell Lung Cancers

Jinyoung Yoo, Chi Hong Kim, So Hyang Song, Byoung Yong Shim, Youn Ju Jeong, Meyung Im Ahn, Sung Whan Kim, Deog Gon Cho, Min Seop Jo, Kyu Do Cho, Hong Joo Cho, Hoon-Kyo Kim

Cancer Res Treat. 2004;36(3):167-172. Published online June 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.3.167

Crossref 5

The Expression of c-myc, bcl-2 and p53 Proteins in Adenocarcinomas of Lung

Jinyoung Yoo, Ji Han Jung, Hyun Joo Choi, Seok Jin Kang, Chang Suk Kang

Cancer Res Treat. 2004;36(2):146-150. Published online April 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.2.146

Crossref 2

p63 and p73 in Tumor Suppression and Promotion

Frank D. McKeon

Cancer Res Treat. 2004;36(1):6-12. Published online February 29, 2004 DOI: https://doi.org/10.4143/crt.2004.36.1.6

Crossref 6

Growth Suppression and Induction of Chemosensitivity in Human Gallbladder Epithelial Carcinoma Cells (GBCE) by Adenovirus-Mediated Transfer of the Wild-type p53 Gene

Sung Bae Kim, Myung Hwan Kim, Sung Koo Lee, Tae Won Kim, Cheolwon Suh, Jeong Sik Shin, Jung Sun Park, Eun Soon Kim, Gyungyub Gong, Jung Shin Lee, Woo Kun Kim, Sang Hee Kim

Cancer Res Treat. 2003;35(6):521-527. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.521

Correlation between p53 and Rb Protein Expression and Clinicopathologic Features in Hepatocellular Carcinoma

Mi Jin Gu, Joon Hyuk Choi

Cancer Res Treat. 2003;35(6):514-520. Published online December 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.6.514

Crossref 1

Clinical Implications of VEGF and p53 Expression in Squamous Cell Carcinoma of the Cervix Treated with Radiation Therapy

Jin Oh Kang, Seong Eon Hong, Dong Wook Kang

Cancer Res Treat. 2003;35(5):440-444. Published online October 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.5.440

Cell-Specific Growth Inhibition of Human Cervical Cancer Cell by Recombinant Adenovirus p53 in vitro and in vivo

Su Mi Bae, Yong Wook Kim, Joo Hee Yoon, Jin Young Yoo, Young Seok Seo, Sang Lyun Nam, Joon Mo Lee, Sung Eun Namkoong, Chong Kook Kim, Yong Wan Kim, Woong Shick Ahn

Cancer Res Treat. 2003;35(3):181-190. Published online June 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.3.181

Crossref 1

Differential Sensitivity of Taxol-induced Apoptosis in U2OS and SaOS2 Osteogenic Sarcoma Cells

Jung Hye Kim, Byung Rho Chin, Seong Yong Kim, Jae Ryong Kim, Suk Hwan Baek

Cancer Res Treat. 2003;35(2):148-153. Published online April 30, 2003 DOI: https://doi.org/10.4143/crt.2003.35.2.148

Crossref 5

Polymorphisms of p53, p21 and IRF-1 and Cervical Cancer Susceptibility in Korean Women

Sung Jong Lee, Sung Eun Namkoong, Won Chul Lee, Jae Woong Sul, Sun Ha Jee, Youn Kyoung You, Jong Eun Lee, Jong Sup Park

Cancer Res Treat. 2002;34(5):357-364. Published online October 31, 2002 DOI: https://doi.org/10.4143/crt.2002.34.5.357

Crossref 3

Clinical Significance of p53, P-glycoprotein, and Glutathione S transferase-pi in Advanced Non-Small Cell Lung Cancer

Young Don Joo, Chang Hak Sohn

Cancer Res Treat. 2002;34(1):34-40. Published online February 28, 2002 DOI: https://doi.org/10.4143/crt.2002.34.1.34

Clinical Analysis of PTEN, p53 and Her-2/neu Expressions in Thyroid Cancers

Jeong Soo Kim, Ja Seong Bae, Kee Hwan Kim, Chang Hyeok Ahn, Se Jeong Oh, Hae Myung Jeon, Keun Woo Lim, Chung Soo Chun

Cancer Res Treat. 2001;33(5):433-437. Published online October 31, 2001 DOI: https://doi.org/10.4143/crt.2001.33.5.433

Crossref 3

E-Cadherin Expression and p53 Alterations in Soft Tissue Sarcomas: A Possible Role in Epithelial Differentiation

Jin Young Yoo, Seok Jin Kang, Woong Shick Ahn, Byung Kee Kim

Cancer Res Treat. 2001;33(4):343-349. Published online August 31, 2001 DOI: https://doi.org/10.4143/crt.2001.33.4.343

Crossref 5

Expression of Cyclin-dependent Kinase Inhibitor p21(WAF1/CIP1) in Non-small Cell Lung Carcinomas: Relationship with p53 Status and Proliferative Activity

Na Hye Myong

Cancer Res Treat. 2001;33(4):329-334. Published online August 31, 2001 DOI: https://doi.org/10.4143/crt.2001.33.4.329

p53 Codon 72 Polymorphism and Cervical Adenocarcinoma Risk in Korean Women

Jeong Hwa Kim, Ju Won Roh, Kyung Sun Kim, Hyeon Jung Jung, Jae Weon Kim, Noh Hyun Park, Yong Sang Song, Soon Beom Kang, Hyo Pyo Lee

Cancer Res Treat. 2001;33(3):243-249. Published online June 30, 2001 DOI: https://doi.org/10.4143/crt.2001.33.3.243

Expression of P53, Bcl-2, Bax, and P-glycoprotein in Relation to Chemotherapeutic Response in Patients with Advanced Non-Small-Cell Lung Cance

Suk Young Park, Eun Hee Lee, Kee Won Kim, Chul Seung Kay, Seok Chan Kim, Ji Won Suhr, Kyung Shick Lee

J Korean Cancer Assoc. 2001;33(2):158-162.

Effect of p53 and p16 Protein Expression in Relation to Body Mass Index for Breast Cancer Risk

Mi Kyung Kim, Jung Yeon Kim, Gyung yub Gong, Sei Hyun Ahn

J Korean Cancer Assoc. 2001;33(2):149-157.

Significance of p53 Immunoreactivity in Squamous Cell Carcinoma of the Cervix Treated with Radiotherapy Alone

Sung Ja Ahn, Ho Sun Choi, Chan Choi, Byung Sik Nah, Woong Ki Chung, Taek Keun Nam

J Korean Cancer Assoc. 2001;33(2):106-112.

Clinical Significance of p53, c-erbB-2, Chromogranin A and PCNA in the Ampullary Carcinoma

Ki Hwan Kim, Sun Whe Kim, Woo Ho Kim, Yong Hyun Park

J Korean Cancer Assoc. 2001;33(1):84-91.

Expression of Cell Cycle Regulatory and Apoptosis-related Proteins in Etoposide-treated Human Skin Fibroblast

Jae We Cho, Min Ho Suh

J Korean Cancer Assoc. 2001;33(1):77-83.